BIOMARCK PHARMACEUTICALS, LTD STTR Phase I Award, September 2019
A STTR Phase I contract was awarded to BioMarck Pharmaceuticals in September, 2019 for $197,556.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.